Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia a with Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00323856
What this trial is testing

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Grifols Biologicals, LLC 51
Early research (Phase 1)UnknownNCT04768699
What this trial is testing

Study of Recombinant Human Coagulation Factor VIIa for Injection (FⅦa) in Patients With Hemophilia.

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00375323
What this trial is testing

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

Who this might be right for
Hemophilia A
Medical University of Vienna
Not applicableLooking for participantsNCT05981274
What this trial is testing

A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

Who this might be right for
Severe Hemophilia A Without Inhibitor
Tri-Service General Hospital (TSGH) 45
Early research (Phase 1)Study completedNCT05651061
What this trial is testing

A Phase I of SS109 in Hemophilia A or and B With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With InhibitorFactor VII Deficiency
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 27
Post-approval studies (Phase 4)Looking for participantsNCT05888870
What this trial is testing

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor

Who this might be right for
Hemophilia A With Inhibitor
Institute of Hematology & Blood Diseases Hospital, China 50
Not applicableLooking for participantsNCT04023019
What this trial is testing

Treatment of Hemophilia A Patients With FVIII Inhibitors

Who this might be right for
Hemophilia A
Emory University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT06569108
What this trial is testing

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Who this might be right for
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Suzhou Alphamab Co., Ltd. 125
Large-scale testing (Phase 3)Ended earlyNCT04489537
What this trial is testing

Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
Catalyst Biosciences 18
Large-scale testing (Phase 3)UnknownNCT05487976
What this trial is testing

Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor

Who this might be right for
Hemophilia AHemophilia B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Not applicableStudy completedNCT00166387
What this trial is testing

Hemophilia Inhibitor Genetics Study (HIGS)

Who this might be right for
Hemophilia A With Inhibitor
Skane University Hospital 1,137
Not applicableStudy completedNCT06357572
What this trial is testing

Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystem

Who this might be right for
Hemophilia A With InhibitorHemophilia A
Enzyre B.V. 6
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Post-approval studies (Phase 4)Ended earlyNCT03204539
What this trial is testing

INdividualized ITI Based on Fviii(ATE) Protection by VWF

Who this might be right for
Hemophilia A With InhibitorHemophilia A
University of California, Davis 1
Large-scale testing (Phase 3)Ended earlyNCT04303559
What this trial is testing

The Hemophilia Inhibitor Prevention Trial

Who this might be right for
Hemophilia A Without Inhibitor
Margaret Ragni 1
Very early researchStudy completedNCT04789954
What this trial is testing

Study on the Dose-response Relationship of Pharmacodynamic Parameters in Patients With Hemophilia With Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia B With Inhibitor
AryoGen Pharmed Co. 14
Not applicableLooking for participantsNCT07096349
What this trial is testing

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Investigación en Hemofilia y Fisioterapia 109
Testing effectiveness (Phase 2)Ended earlyNCT05789537
What this trial is testing

SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors

Who this might be right for
Hemophilia B with InhibitorHemophilia B
ApcinteX Ltd 3
Post-approval studies (Phase 4)Not Yet RecruitingNCT07158606
What this trial is testing

Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction

Who this might be right for
Hemophilia A With Inhibitor
Versiti Blood Health 15
Post-approval studies (Phase 4)Study completedNCT00284193
What this trial is testing

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII

Who this might be right for
Hemophilia A
Sheba Medical Center 5
Next Page